# Monitoring Minimal Residual Disease in Gastric Cancer by Liquid Biopsy Study Description

> **NCT05029869** · — · ACTIVE_NOT_RECRUITING · sponsor: **University Medical Center Ho Chi Minh City (UMC)** · enrollment: 100 (estimated)

## Conditions studied

- Gastric Cancer
- ctDNA

## Interventions

- **DIAGNOSTIC_TEST:** ctDNA

## Key facts

- **NCT ID:** NCT05029869
- **Lead sponsor:** University Medical Center Ho Chi Minh City (UMC)
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-10-04
- **Primary completion:** 2026-12-30
- **Final completion:** 2026-12-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05029869

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05029869, "Monitoring Minimal Residual Disease in Gastric Cancer by Liquid Biopsy Study Description". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05029869. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*